Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-6-23
pubmed:abstractText
Esophagectomy for esophageal cancer is associated with substantial postoperative morbidity as a result of infectious complications. In a prior phase II study, granulocyte colony-stimulating factor (G-CSF) was shown to improve leukocyte function and to reduce infection rates after esophagectomy. The aim of the current randomized, placebo-controlled, multicenter phase III trial was to investigate the clinical efficacy of perioperative G-CSF administration in reducing infection and mortality after esophagectomy for esophageal cancer.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-10075357, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-10803937, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-10950800, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-11098963, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-11171733, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-11257020, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-11301408, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-11565672, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-11904116, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-12519588, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-1331619, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-1596128, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-3395815, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-3594139, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-6824878, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-7165009, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-7482272, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-7786985, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-8582499, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-8833041, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-8980882, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-9230656, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-9310604, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-9559614, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-9641012, http://linkedlifedata.com/resource/pubmed/commentcorrection/15213620-9806037
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0003-4932
pubmed:author
pubmed:issnType
Print
pubmed:volume
240
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
68-75
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15213620-Adult, pubmed-meshheading:15213620-Aged, pubmed-meshheading:15213620-Anti-Infective Agents, pubmed-meshheading:15213620-Double-Blind Method, pubmed-meshheading:15213620-Esophageal Neoplasms, pubmed-meshheading:15213620-Esophagectomy, pubmed-meshheading:15213620-Female, pubmed-meshheading:15213620-Granulocyte Colony-Stimulating Factor, pubmed-meshheading:15213620-Humans, pubmed-meshheading:15213620-Infection, pubmed-meshheading:15213620-Male, pubmed-meshheading:15213620-Mediastinitis, pubmed-meshheading:15213620-Middle Aged, pubmed-meshheading:15213620-Perioperative Care, pubmed-meshheading:15213620-Pneumonia, pubmed-meshheading:15213620-Postoperative Complications, pubmed-meshheading:15213620-Premedication, pubmed-meshheading:15213620-Recombinant Proteins, pubmed-meshheading:15213620-Risk Factors, pubmed-meshheading:15213620-Sepsis, pubmed-meshheading:15213620-Surgical Wound Infection, pubmed-meshheading:15213620-Urinary Tract Infections
pubmed:year
2004
pubmed:articleTitle
Perioperative granulocyte colony-stimulating factor does not prevent severe infections in patients undergoing esophagectomy for esophageal cancer: a randomized placebo-controlled clinical trial.
pubmed:affiliation
Department of Visceral and Vascular Surgery, University of Cologne, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III